Mark Pollack

Title	Professor
Institution	Rush University, Rush Medical College
Department	Psychiatry
Address	1645 W. Jackson Blvd. Chicago IL 60612
Phone	312-942-5372
vCard	Download vCard

Overview

overview

My Scopus ID is 7201625274.
My NIH COMMONS name is MPOLLACK.

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Taylor CT, Rosenfield D, Dowd SM, Dutcher CD, Hofmann SG, Otto MW, Pollack MH, Smits JAJ. What good are positive emotions for treatment? A replication test of whether trait positive emotionality predicts response to exposure therapy for social anxiety disorder. Behav Res Ther. 2023 12; 171:104436. PMID: 37979218.

Citations:
Lubin RE, Fitzgerald HE, Rosenfield D, Carpenter JK, Papini S, Dutcher CD, Dowd SM, Hofmann SG, Pollack MH, Smits JAJ, Otto MW. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT. J Psychiatr Res. 2023 08; 164:357-363. PMID: 37399757.

Citations:
Sung SC, Lim L, Lim SH, Finkelstein EA, Chin SLH, Annathurai A, Chakraborty B, Strauman TJ, Pollack MH, Ong MEH. Protocol for a multi-site randomized controlled trial of a stepped-care intervention for emergency department patients with panic-related anxiety. BMC Psychiatry. 2022 Dec 16; 22(1):795. PMID: 36527018.

Citations:
Voigt RM, Zalta AK, Raeisi S, Zhang L, Brown JM, Forsyth CB, Boley RA, Held P, Pollack MH, Keshavarzian A. Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms. Am J Physiol Gastrointest Liver Physiol. 2022 08 01; 323(2):G61-G70. PMID: 35638693.

Citations:
Dutcher CD, Dowd SM, Zalta AK, Taylor DJ, Rosenfield D, Perrone A, Otto MW, Pollack MH, Hofmann SG, Smits JAJ. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder. Depress Anxiety. 2021 11; 38(11):1182-1190. PMID: 34010494.

Citations:
Post LM, Held P, Smith DL, Black K, Van Horn R, Pollack MH, Rothbaum BO, Rauch SAM. Impact of intensive treatment programs for posttraumatic stress disorder on suicidal ideation in veterans and service members. Psychol Serv. 2021 Nov; 18(4):671-678. PMID: 33829834.

Citations:
Held P, Zalta AK, Smith DL, Bagley JM, Steigerwald VL, Boley RA, Miller M, Brennan MB, Van Horn R, Pollack MH. Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans. Eur J Psychotraumatol. 2020 Aug 12; 11(1):1789324. PMID: 33029327.

Citations:
Smits JAJ, Pollack MH, Rosenfield D, Otto MW, Dowd S, Carpenter J, Dutcher CD, Lewis EM, Witcraft SM, Papini S, Curtiss J, Andrews L, Kind S, Conroy K, Hofmann SG. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2020 06 01; 3(6):e206777. PMID: 32496566.

Citations:
Held P, Boley RA, Faig WG, O'Toole JA, Desai I, Zalta AK, Khan J, Sims S, Brennan MB, Van Horn R, Glover AC, Hota BN, Patty BD, Rab SS, Pollack MH, Karnik NS. The Postencounter Form System: Viewpoint on Efficient Data Collection Within Electronic Health Records. JMIR Form Res. 2020 Apr 06; 4(4):e17429. PMID: 32250276.

Citations:
Zalta AK, Pinkerton LM, Valdespino-Hayden Z, Smith DL, Burgess HJ, Held P, Boley RA, Karnik NS, Pollack MH. Examining Insomnia During Intensive Treatment for Veterans with Posttraumatic Stress Disorder: Does it Improve and Does it Predict Treatment Outcomes? J Trauma Stress. 2020 08; 33(4):521-527. PMID: 32216141.

Citations:
Dowd SM, Zalta AK, Burgess HJ, Adkins EC, Valdespino-Hayden Z, Pollack MH. Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia. World J Psychiatry. 2020 Mar 19; 10(3):21-28. PMID: 32257848.

Citations:
Lofgreen AM, Tirone V, Carroll KK, Rufa AK, Smith DL, Bagley J, Zalta AK, Brennan MB, Van Horn R, Pollack MH, Held P. Improving outcomes for a 3-week intensive treatment program for posttraumatic stress disorder in survivors of military sexual trauma. J Affect Disord. 2020 05 15; 269:134-140. PMID: 32250866.

Citations:
Miller ML, Bagley JM, Normand P, Brennan MB, Van Horn R, Pollack MH, Held P. Increasing Mindfulness Skills of Veterans With PTSD Through Daily Mindfulness Training Incorporated Into an Intensive Treatment Program. Mindfulness (N Y). 2021 Apr; 11(4):964-974. PMID: 34367355.

Citations:
Tirone V, Smith D, Steigerwald VL, Bagley JM, Brennan M, Van Horn R, Pollack M, Held P. Examining the Impact of Sexual Revictimization in a Sample of Veterans Undergoing Intensive PTSD Treatment. J Interpers Violence. 2021 12; 36(23-24):10989-11008. PMID: 31898925.

Citations:
Thompson HM, Hill K, Jadhav R, Webb TA, Pollack M, Karnik N. The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center. J Addict Med. 2019 Nov/Dec; 13(6):460-463. PMID: 31689260.

Citations:
Hofmann SG, Papini S, Carpenter JK, Otto MW, Rosenfield D, Dutcher CD, Dowd S, Lewis M, Witcraft S, Pollack MH, Smits JAJ. Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder. PLoS One. 2019; 14(10):e0223729. PMID: 31622374.

Citations:
Rosenfield D, Smits JAJ, Hofmann SG, Mataix-Cols D, de la Cruz LF, Andersson E, R?ck C, Monzani B, P?rez-Vigil A, Frumento P, Davis M, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Storch EA, Str?hle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner CA, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P, Turner C, Otto MW. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149. PMID: 31698111.

Citations:
Held P, Klassen BJ, Small CF, Brennan MB, Horn RV, Karnik NS, Pollack MH, Zalta AK. A Case Report of Cognitive Processing Therapy Delivered over a Single Week. Cogn Behav Pract. 2020 May; 27(2):126-135. PMID: 33041618.

Citations:
Held P, Klassen BJ, Boley RA, Wiltsey Stirman S, Smith DL, Brennan MB, Van Horn R, Pollack MH, Karnik NS, Zalta AK. Feasibility of a 3-week intensive treatment program for service members and veterans with PTSD. Psychol Trauma. 2020 May; 12(4):422-430. PMID: 31318250.

Citations:
Thompson H, Faig W, Gupta N, Lahey R, Golden R, Pollack M, Karnik N. Collaborative Care for Depression of Adults and Adolescents: Measuring the Effectiveness of Screening and Treatment Uptake. Psychiatr Serv. 2019 07 01; 70(7):604-607. PMID: 31023189.

Citations:
Zalta AK, Bravo K, Valdespino-Hayden Z, Pollack MH, Burgess HJ. A placebo-controlled pilot study of a wearable morning bright light treatment for probable PTSD. Depress Anxiety. 2019 07; 36(7):617-624. PMID: 30995350.

Citations:
Burgess HJ, Rizvydeen M, Kimura M, Pollack MH, Hobfoll SE, Rajan KB, Burns JW. An Open Trial of Morning Bright Light Treatment Among US Military Veterans with Chronic Low Back Pain: A Pilot Study. Pain Med. 2019 04 01; 20(4):770-778. PMID: 30204903.

Citations:
Burgess HJ, Kikyo F, Valdespino-Hayden Z, Rizvydeen M, Kimura M, Pollack MH, Hobfoll SE, Rajan KB, Zalta AK, Burns JW. Do the Morningness-Eveningness Questionnaire and Munich ChronoType Questionnaire Change After Morning Light Treatment? Sleep Sci Pract. 2018; 2. PMID: 31289751.

Citations:
Zalta AK, Held P, Smith DL, Klassen BJ, Lofgreen AM, Normand PS, Brennan MB, Rydberg TS, Boley RA, Pollack MH, Karnik NS. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD. BMC Psychiatry. 2018 07 27; 18(1):242. PMID: 30053860.

Citations:
Horwitz AG, Held P, Klassen BJ, Karnik NS, Pollack MH, Zalta AK. Posttraumatic Cognitions and Suicidal Ideation among Veterans receiving PTSD Treatment. Cognit Ther Res. 2018 Oct; 42(5):711-719. PMID: 30505042.

Citations:
Carroll KK, Lofgreen AM, Weaver DC, Held P, Klassen BJ, Smith DL, Karnik NS, Pollack MH, Zalta AK. Negative posttraumatic cognitions among military sexual trauma survivors. J Affect Disord. 2018 10 01; 238:88-93. PMID: 29864715.

Citations:
Held P, Klassen BJ, Hall JM, Friese TR, Bertsch-Gout MM, Zalta AK, Pollack MH. "I knew it was wrong the moment I got the order": A narrative thematic analysis of moral injury in combat veterans. Psychol Trauma. 2019 May; 11(4):396-405. PMID: 29723032.

Citations:
Zalta AK, Bui E, Karnik NS, Held P, Laifer LM, Sager JC, Zou D, Rauch PK, Simon NM, Pollack MH, Ohye B. Examining the Relationship Between Parent and Child Psychopathology in Treatment-Seeking Veterans. Child Psychiatry Hum Dev. 2018 04; 49(2):209-216. PMID: 28660407.

Citations:
Stathopoulou G, Pollack MH, Otto MW. Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients. Addict Behav. 2018 09; 84:75-78. PMID: 29631093.

Citations:
Pollack MH, Betof A, Dearden H, Rapazzo K, Valentine I, Brohl AS, Ancell KK, Long GV, Menzies AM, Eroglu Z, Johnson DB, Shoushtari AN. Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2018 01 01; 29(1):250-255. PMID: 29045547.

Citations:
Roque AD, Rosenfield D, Smits JAJ, Simon N, Otto MW, Marques L, Pollack MH, Hofmann SG, Meuret AE. Does d-cycloserine facilitate the effects of homework compliance on social anxiety symptom reduction? J Anxiety Disord. 2018 01; 53:85-90. PMID: 29227845.

Citations:
Held P, Klassen BJ, Zou DS, Schroedter BS, Karnik NS, Pollack MH, Zalta AK. Negative Posttrauma Cognitions Mediate the Association Between Morally Injurious Events and Trauma-Related Psychopathology in Treatment-Seeking Veterans. J Trauma Stress. 2017 12; 30(6):698-703. PMID: 29140560.

Citations:
Pollack MH, Simon NM, Rothbaum BO. Care of Veterans Through the Warrior Care Network. Focus (Am Psychiatr Publ). 2017 Oct; 15(4):377. PMID: 31975866.

Citations:
Harvey MM, Rauch SAM, Zalta AK, Sornborger J, Pollack MH, Rothbaum BO, Laifer LM, Simon NM. Intensive Treatment Models to Address Posttraumatic Stress Among Post-9/11 Warriors: The Warrior Care Network. Focus (Am Psychiatr Publ). 2017 Oct; 15(4):378-383. PMID: 31975867.

Citations:
Held P, Klassen BJ, Zalta AK, Pollack MH. Understanding the Impact and Treatment of Moral Injury Among Military Service Members. Focus (Am Psychiatr Publ). 2017 Oct; 15(4):399-405. PMID: 31975870.

Citations:
Held P, Boley RA, Karnik NS, Pollack MH, Zalta AK. Characteristics of veterans and military service members who endorse causing harm, injury, or death to others in the military. Psychol Trauma. 2018 May; 10(3):352-359. PMID: 28758768.

Citations:
Mataix-Cols D, Fern?ndez de la Cruz L, Monzani B, Rosenfield D, Andersson E, P?rez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Str?hle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, R?ck C, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510. PMID: 28122091.

Citations:
Hoge EA, Bui E, Palitz SA, Schwarz NR, Owens ME, Johnston JM, Pollack MH, Simon NM. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder. Psychiatry Res. 2018 04; 262:328-332. PMID: 28131433.

Citations:
Hoge EA, Guidos BM, Mete M, Bui E, Pollack MH, Simon NM, Dutton MA. Effects of mindfulness meditation on occupational functioning and health care utilization in individuals with anxiety. J Psychosom Res. 2017 04; 95:7-11. PMID: 28314552.

Citations:
Otto MW, Pollack MH, Dowd SM, Hofmann SG, Pearlson G, Szuhany KL, Gueorguieva R, Krystal JH, Simon NM, Tolin DF. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. Depress Anxiety. 2016 08; 33(8):737-45. PMID: 27315514.

Citations:
Zalta AK, Tirone V, Siedjak J, Boley RA, Vechiu C, Pollack MH, Hobfoll SE. A Pilot Study of Tailored Cognitive-Behavioral Resilience Training for Trauma Survivors With Subthreshold Distress. J Trauma Stress. 2016 06; 29(3):268-72. PMID: 27121865.

Citations:
Meuret AE, Chmielewski M, Steele AM, Rosenfield D, Petersen S, Smits JA, Simon NM, Otto MW, Marques L, Pollack MH, Hofmann SG. The desire to belong: Social identification as a predictor of treatment outcome in social anxiety disorder. Behav Res Ther. 2016 06; 81:21-34. PMID: 27070526.

Citations:
Otto MW, Kredlow MA, Smits JAJ, Hofmann SG, Tolin DF, de Kleine RA, van Minnen A, Evins AE, Pollack MH. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions. Biol Psychiatry. 2016 08 15; 80(4):274-283. PMID: 26520240.

Citations:
Mundy EA, Weber M, Rauch SL, Killgore WD, Simon NM, Pollack MH, Rosso IM. ADULT ANXIETY DISORDERS IN RELATION TO TRAIT ANXIETY AND PERCEIVED STRESS IN CHILDHOOD. Psychol Rep. 2015 Oct; 117(2):473-89. PMID: 26340052.

Citations:
Whitfield-Gabrieli S, Ghosh SS, Nieto-Castanon A, Saygin Z, Doehrmann O, Chai XJ, Reynolds GO, Hofmann SG, Pollack MH, Gabrieli JD. Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2016 May; 21(5):680-5. PMID: 26260493.

Citations:
Hofmann SG, Carpenter JK, Otto MW, Rosenfield D, Smits JA, Pollack MH. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. Contemp Clin Trials. 2015 Jul; 43:223-30. PMID: 26111923.

Citations:
Manning J, Reynolds G, Saygin ZM, Hofmann SG, Pollack M, Gabrieli JD, Whitfield-Gabrieli S. Altered resting-state functional connectivity of the frontal-striatal reward system in social anxiety disorder. PLoS One. 2015; 10(4):e0125286. PMID: 25928647.

Citations:
Hofmann SG, Otto MW, Pollack MH, Smits JA. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Curr Psychiatry Rep. 2015 Jan; 17(1):532. PMID: 25413638.

Citations:
Webb AK, Vincent AL, Jin AB, Pollack MH. Physiological reactivity to nonideographic virtual reality stimuli in veterans with and without PTSD. Brain Behav. 2015 Feb; 5(2):e00304. PMID: 25642387.

Citations:
Otto MW, Hearon BA, McHugh RK, Calkins AW, Pratt E, Murray HW, Safren SA, Pollack MH. A randomized, controlled trial of the efficacy of an interoceptive exposure-based CBT for treatment-refractory outpatients with opioid dependence. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):402-11. PMID: 25364993.

Citations:
Pollack MH, Stein M, Simon N, Van Ameringen M. Response to Silberman. Am J Psychiatry. 2014 Jul; 171(7):795-6. PMID: 24980175.

Citations:
Smoller JW, Gallagher PJ, Duncan LE, McGrath LM, Haddad SA, Holmes AJ, Wolf AB, Hilker S, Block SR, Weill S, Young S, Choi EY, Rosenbaum JF, Biederman J, Faraone SV, Roffman JL, Manfro GG, Blaya C, Hirshfeld-Becker DR, Stein MB, Van Ameringen M, Tolin DF, Otto MW, Pollack MH, Simon NM, Buckner RL, Ong?r D, Cohen BM. The human ortholog of acid-sensing ion channel gene ASIC1a is associated with panic disorder and amygdala structure and function. Biol Psychiatry. 2014 Dec 01; 76(11):902-10. PMID: 24529281.

Citations:
Otto MW, Moshier SJ, Kinner DG, Simon NM, Pollack MH, Orr SP. De novo fear conditioning across diagnostic groups in the affective disorders: evidence for learning impairments. Behav Ther. 2014 Sep; 45(5):619-29. PMID: 25022773.

Citations:
Pollack MH, Van Ameringen M, Simon NM, Worthington JW, Hoge EA, Keshaviah A, Stein MB. A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry. 2014 Jan; 171(1):44-53. PMID: 24399428.

Citations:
Stein MB, Keshaviah A, Haddad SA, Van Ameringen M, Simon NM, Pollack MH, Smoller JW. Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacology. 2014 May; 39(6):1340-6. PMID: 24154666.

Citations:
Zalta AK, Dowd S, Rosenfield D, Smits JA, Otto MW, Simon NM, Meuret AE, Marques L, Hofmann SG, Pollack MH. Sleep quality predicts treatment outcome in CBT for social anxiety disorder. Depress Anxiety. 2013 Nov; 30(11):1114-20. PMID: 24038728.

Citations:
Smits JA, Hofmann SG, Rosenfield D, DeBoer LB, Costa PT, Simon NM, O'Cleirigh C, Meuret AE, Marques L, Otto MW, Pollack MH. D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables. J Consult Clin Psychol. 2013 Dec; 81(6):1100-12. PMID: 23937345.

Citations:
Anderson EC, Dryman MT, Worthington J, Hoge EA, Fischer LE, Pollack MH, Barrett LF, Simon NM. Smiles may go unseen in generalized social anxiety disorder: evidence from binocular rivalry for reduced visual consciousness of positive facial expressions. J Anxiety Disord. 2013 Oct; 27(7):619-26. PMID: 24064330.

Citations:
Hoge EA, Bui E, Marques L, Metcalf CA, Morris LK, Robinaugh DJ, Worthington JJ, Pollack MH, Simon NM. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug; 74(8):786-92. PMID: 23541163.

Citations:
Killgore WD, Britton JC, Schwab ZJ, Price LM, Weiner MR, Gold AL, Rosso IM, Simon NM, Pollack MH, Rauch SL. Cortico-limbic responses to masked affective faces across ptsd, panic disorder, and specific phobia. Depress Anxiety. 2014 Feb; 31(2):150-9. PMID: 23861215.

Citations:
Smits JA, Rosenfield D, Otto MW, Marques L, Davis ML, Meuret AE, Simon NM, Pollack MH, Hofmann SG. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. J Psychiatr Res. 2013 Oct; 47(10):1455-61. PMID: 23870811.

Citations:
Hofmann SG, Smits JA, Rosenfield D, Simon N, Otto MW, Meuret AE, Marques L, Fang A, Tart C, Pollack MH. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Am J Psychiatry. 2013 Jul; 170(7):751-8. PMID: 23599046.

Citations:
Bui E, Orr SP, Jacoby RJ, Keshaviah A, LeBlanc NJ, Milad MR, Pollack MH, Simon NM. Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals. Hum Psychopharmacol. 2013 Sep; 28(5):447-56. PMID: 23776033.

Citations:
Aderka IM, Pollack MH, Simon NM, Smits JA, Van Ameringen M, Stein MB, Hofmann SG. Development of a brief version of the Social Phobia Inventory using item response theory: the Mini-SPIN-R. Behav Ther. 2013 Dec; 44(4):651-61. PMID: 24094790.

Citations:
Weber M, Killgore WD, Rosso IM, Britton JC, Schwab ZJ, Weiner MR, Simon NM, Pollack MH, Rauch SL. Voxel-based morphometric gray matter correlates of posttraumatic stress disorder. J Anxiety Disord. 2013 May; 27(4):413-9. PMID: 23746489.

Citations:
Hoge EA, Chen MM, Orr E, Metcalf CA, Fischer LE, Pollack MH, De Vivo I, Simon NM. Loving-Kindness Meditation practice associated with longer telomeres in women. Brain Behav Immun. 2013 Aug; 32:159-63. PMID: 23602876.

Citations:
Smits JA, Rosenfield D, Otto MW, Powers MB, Hofmann SG, Telch MJ, Pollack MH, Tart CD. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry. 2013 Jun 01; 73(11):1054-8. PMID: 23332511.

Citations:
Doehrmann O, Ghosh SS, Polli FE, Reynolds GO, Horn F, Keshavan A, Triantafyllou C, Saygin ZM, Whitfield-Gabrieli S, Hofmann SG, Pollack M, Gabrieli JD. Predicting treatment response in social anxiety disorder from functional magnetic resonance imaging. JAMA Psychiatry. 2013 Jan; 70(1):87-97. PMID: 22945462.

Citations:
McHugh RK, Murray HW, Hearon BA, Pratt EM, Pollack MH, Safren SA, Otto MW. Predictors of dropout from psychosocial treatment in opioid-dependent outpatients. Am J Addict. 2013 Jan; 22(1):18-22. PMID: 23398222.

Citations:
Tart CD, Handelsman PR, Deboer LB, Rosenfield D, Pollack MH, Hofmann SG, Powers MB, Otto MW, Smits JA. Augmentation of exposure therapy with post-session administration of D-cycloserine. J Psychiatr Res. 2013 Feb; 47(2):168-74. PMID: 23098672.

Citations:
Hoge EA, Lawson EA, Metcalf CA, Keshaviah A, Zak PJ, Pollack MH, Simon NM. Plasma oxytocin immunoreactive products and response to trust in patients with social anxiety disorder. Depress Anxiety. 2012 Nov; 29(11):924-30. PMID: 22807189.

Citations:
McHugh RK, Weitzman M, Safren SA, Murray HW, Pollack MH, Otto MW. Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample. J Psychoactive Drugs. 2012 Jul-Aug; 44(3):237-42. PMID: 23061323.

Citations:
Marques L, Porter E, Keshaviah A, Pollack MH, Van Ameringen M, Stein MB, Simon NM. Avoidant personality disorder in individuals with generalized social anxiety disorder: what does it add? J Anxiety Disord. 2012 Aug; 26(6):665-72. PMID: 22705954.

Citations:
Safren SA, O'Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012 Jun; 80(3):404-15. PMID: 22545737.

Citations:
Keough ME, Porter E, Kredlow MA, Worthington JJ, Hoge EA, Pollack MH, Shear MK, Simon NM. Anchoring the Panic Disorder Severity Scale. Assessment. 2012 Jun; 19(2):257-9. PMID: 22327206.

Citations:
Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M. A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97. PMID: 22286203.

Citations:
Sung SC, Porter E, Robinaugh DJ, Marks EH, Marques LM, Otto MW, Pollack MH, Simon NM. Mood regulation and quality of life in social anxiety disorder: an examination of generalized expectancies for negative mood regulation. J Anxiety Disord. 2012 Apr; 26(3):435-41. PMID: 22343166.

Citations:
Hinton DE, Kredlow MA, Bui E, Pollack MH, Hofmann SG. Treatment change of somatic symptoms and cultural syndromes among Cambodian refugees with PTSD. Depress Anxiety. 2012 Feb; 29(2):147-54. PMID: 22065554.

Citations:
Mischoulon D, Witte J, Levy M, Papakostas GI, Pet LR, Hsieh WH, Pencina MJ, Ward S, Pollack MH, Fava M. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. J Clin Psychiatry. 2012 Mar; 73(3):353-7. PMID: 21939613.

Citations:
Robinaugh DJ, Marques L, Traeger LN, Marks EH, Sung SC, Gayle Beck J, Pollack MH, Simon NM. Understanding the relationship of perceived social support to post-trauma cognitions and posttraumatic stress disorder. J Anxiety Disord. 2011 Dec; 25(8):1072-8. PMID: 21820854.

Citations:
Pollack MH, Hoge EA, Worthington JJ, Moshier SJ, Wechsler RS, Brandes M, Simon NM. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 Jul; 72(7):892-7. PMID: 21367352.

Citations:
Hinton DE, Hofmann SG, Rivera E, Otto MW, Pollack MH. Culturally adapted CBT (CA-CBT) for Latino women with treatment-resistant PTSD: a pilot study comparing CA-CBT to applied muscle relaxation. Behav Res Ther. 2011 Apr; 49(4):275-80. PMID: 21333272.

Citations:
Hoge EA, Marques L, Wechsler RS, Lasky AK, Delong HR, Jacoby RJ, Worthington JJ, Pollack MH, Simon NM. The role of anxiety sensitivity in sleep disturbance in panic disorder. J Anxiety Disord. 2011 May; 25(4):536-8. PMID: 21277737.

Citations:
Hoge EA, Worthington JJ, Nagurney JT, Chang Y, Kay EB, Feterowski CM, Katzman AR, Goetz JM, Rosasco ML, Lasko NB, Zusman RM, Pollack MH, Orr SP, Pitman RK. Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012 Jan; 18(1):21-7. PMID: 22070357.

Citations:
Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther. 2010 Oct; 16(5):322-5. PMID: 19769599.

Citations:
Applebaum AJ, Bullis JR, Traeger LN, O'cleirigh C, Otto MW, Pollack MH, Safren SA. Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status. Neurobehav HIV Med. 2010 Aug 10; 2010(2):49-57. PMID: 24062619.

Citations:
Simon NM, Worthington JJ, Moshier SJ, Marks EH, Hoge EA, Brandes M, Delong H, Pollack MH. Duloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response. CNS Spectr. 2010 Jul; 15(7):367-73. PMID: 20625362.

Citations:
Hinton DE, Pich V, Marques L, Nickerson A, Pollack MH. Khy?l attacks: a key idiom of distress among traumatized cambodia refugees. Cult Med Psychiatry. 2010 Jun; 34(2):244-78. PMID: 20407813.

Citations:
Otto MW, McHugh RK, Simon NM, Farach FJ, Worthington JJ, Pollack MH. Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation. Behav Res Ther. 2010 Aug; 48(8):720-7. PMID: 20546699.

Citations:
Stein MB, Ravindran LN, Simon NM, Liebowitz MR, Khan A, Brawman-Mintzer O, Lydiard RB, Pollack MH. Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31. PMID: 20021997.

Citations:
Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, Lebeau RT, Moshier SJ, Zalta AK, Pollack MH. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. J Clin Psychiatry. 2009 Nov; 70(11):1563-70. PMID: 19814948.

Citations:
Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010 Feb 15; 67(4):365-70. PMID: 19811776.

Citations:
Hinton DE, Rasmussen A, Nou L, Pollack MH, Good MJ. Anger, PTSD, and the nuclear family: a study of Cambodian refugees. Soc Sci Med. 2009 Nov; 69(9):1387-94. PMID: 19748169.

Citations:
Hinton DE, Hinton AL, Pich V, Loeum JR, Pollack MH. Nightmares among Cambodian refugees: the breaching of concentric ontological security. Cult Med Psychiatry. 2009 Jun; 33(2):219-65. PMID: 19333741.

Citations:
Kaufman RE, Ostacher MJ, Marks EH, Simon NM, Sachs GS, Jensen JE, Renshaw PF, Pollack MH. Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Apr 30; 33(3):427-34. PMID: 19171176.

Citations:
Hinton DE, Lewis-Fern?ndez R, Pollack MH. A model of the generation of ataque de nervios: the role of fear of negative affect and fear of arousal symptoms. CNS Neurosci Ther. 2009; 15(3):264-75. PMID: 19691546.

Citations:
Pollack MH. Refractory generalized anxiety disorder. J Clin Psychiatry. 2009; 70 Suppl 2:32-8. PMID: 19371505.

Citations:
Simon NM, Kaufman RE, Hoge EA, Worthington JJ, Herlands NN, Owens ME, Pollack MH. Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther. 2009; 15(1):19-23. PMID: 19228176.

Citations:
Hinton DE, Pollack MH. Introduction to the special issue: anxiety disorders in cross-cultural perspective. CNS Neurosci Ther. 2009; 15(3):207-9. PMID: 19691539.

Citations:
Hinton DE, Hofmann SG, Pollack MH, Otto MW. Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure response. CNS Neurosci Ther. 2009; 15(3):255-63. PMID: 19691545.

Citations:
Marques L, Kaufman RE, LeBeau RT, Moshier SJ, Otto MW, Pollack MH, Simon NM. A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controls. CNS Neurosci Ther. 2009; 15(2):100-6. PMID: 19492991.

Citations:
Simon NM, Herlands NN, Marks EH, Mancini C, Letamendi A, Li Z, Pollack MH, Van Ameringen M, Stein MB. Childhood maltreatment linked to greater symptom severity and poorer quality of life and function in social anxiety disorder. Depress Anxiety. 2009; 26(11):1027-32. PMID: 19750554.

Citations:
Hinton DE, Park L, Hsia C, Hofmann S, Pollack MH. Anxiety disorder presentations in Asian populations: a review. CNS Neurosci Ther. 2009; 15(3):295-303. PMID: 19691549.

Citations:
Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009; 26(5):447-55. PMID: 19319993.

Citations:
Davidson J, Allgulander C, Pollack MH, Hartford J, Erickson JS, Russell JM, Perahia D, Wohlreich MM, Carlson J, Raskin J. Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. Hum Psychopharmacol. 2008 Aug; 23(6):519-26. PMID: 18478624.

Citations:
Evans KC, Simon NM, Dougherty DD, Hoge EA, Worthington JJ, Chow C, Kaufman RE, Gold AL, Fischman AJ, Pollack MH, Rauch SL. A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorder. Neuropsychopharmacology. 2009 Jan; 34(2):390-8. PMID: 18536708.

Citations:
Hinton DE, Hinton SD, Loeum RJ, Pich V, Pollack MH. The 'multiplex model' of somatic symptoms: application to tinnitus among traumatized Cambodian refugees. Transcult Psychiatry. 2008 Jun; 45(2):287-317. PMID: 18562496.

Citations:
Hoge EA, Worthington JJ, Kaufman RE, Delong HR, Pollack MH, Simon NM. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spectr. 2008 Jun; 13(6):522-7. PMID: 18567977.

Citations:
Pollack MH, Tiller J, Xie F, Trivedi MH. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16. PMID: 18480688.

Citations:
Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry. 2008 May; 65(5):551-62. PMID: 18458207.

Citations:
George MS, Ward HE, Ninan PT, Pollack M, Nahas Z, Anderson B, Kose S, Howland RH, Goodman WK, Ballenger JC. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21. PMID: 20633378.

Citations:
Pollack MH, Kornstein SG, Spann ME, Crits-Christoph P, Raskin J, Russell JM. Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint. J Psychiatr Res. 2008 Oct; 42(14):1176-84. PMID: 18348888.

Citations:
Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH. Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar; 69(3):400-5. PMID: 18348595.

Citations:
Simon NM, Connor KM, LeBeau RT, Hoge EA, Worthington JJ, Zhang W, Davidson JR, Pollack MH. Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology (Berl). 2008 May; 197(4):675-81. PMID: 18246327.

Citations:
Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment. J Psychiatr Res. 2008 Oct; 42(12):1042-9. PMID: 18221755.

Citations:
Olatunji BO, Feldman G, Smits JA, Christian KM, Zalta AK, Pollack MH, Simon NM. Examination of the decline in symptoms of anxiety and depression in generalized anxiety disorder: impact of anxiety sensitivity on response to pharmacotherapy. Depress Anxiety. 2008; 25(2):167-71. PMID: 17335002.

Citations:
Pollack MH. Changing times at CNS Neuroscience & Therapeutics. CNS Neurosci Ther. 2008; 14(1):1. PMID: 18482093.

Citations:
Pollack MH, Otto MW, Roy-Byrne PP, Coplan JD, Rothbaum BO, Simon NM, Gorman JM. Novel treatment approaches for refractory anxiety disorders. Depress Anxiety. 2008; 25(6):467-76. PMID: 17437259.

Citations:
Hoge EA, Pollack MH, Kaufman RE, Zak PJ, Simon NM. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther. 2008; 14(3):165-70. PMID: 18801109.

Citations:
Hinton DE, Chong R, Pollack MH, Barlow DH, McNally RJ. Ataque de nervios: relationship to anxiety sensitivity and dissociation predisposition. Depress Anxiety. 2008; 25(6):489-95. PMID: 17570492.

Citations:
Hinton DE, Hofmann SG, Pitman RK, Pollack MH, Barlow DH. The panic attack-posttraumatic stress disorder model: applicability to orthostatic panic among Cambodian refugees. Cogn Behav Ther. 2008; 37(2):101-16. PMID: 18470741.

Citations:
Targum SD, Pollack MH, Fava M. Redefining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008; 14(1):2-9. PMID: 18482094.

Citations:
Evans KC, Wright CI, Wedig MM, Gold AL, Pollack MH, Rauch SL. A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety. 2008; 25(6):496-505. PMID: 17595018.

Citations:
Maytal G, Zalta AK, Thompson E, Chow CW, Perlman C, Ostacher MJ, Pollack MH, Shear K, Simon NM. Complicated grief and impaired sleep in patients with bipolar disorder. Bipolar Disord. 2007 Dec; 9(8):913-7. PMID: 18076543.

Citations:
Hinton DE, Hinton L, Tran M, Nguyen M, Nguyen L, Hsia C, Pollack MH. Orthostatic panic attacks among Vietnamese refugees. Transcult Psychiatry. 2007 Dec; 44(4):515-44. PMID: 18089637.

Citations:
Pollack MH, Jensen JE, Simon NM, Kaufman RE, Renshaw PF. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 01; 32(3):739-43. PMID: 18206286.

Citations:
Simon NM, Thompson EH, Pollack MH, Shear MK. Complicated grief: a case series using escitalopram. Am J Psychiatry. 2007 Nov; 164(11):1760-1. PMID: 17974946.

Citations:
Smoller JW, Pollack MH, Wassertheil-Smoller S, Jackson RD, Oberman A, Wong ND, Sheps D. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry. 2007 Oct; 64(10):1153-60. PMID: 17909127.

Citations:
Taylor CT, Hirshfeld-Becker DR, Ostacher MJ, Chow CW, LeBeau RT, Pollack MH, Nierenberg AA, Simon NM. Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord. 2008 Jun; 22(5):868-76. PMID: 17936573.

Citations:
Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, Nierenberg AA, Fava M, Wong KK. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2008 Mar; 18(3):230-3. PMID: 17681762.

Citations:
Kinrys G, Worthington JJ, Wygant L, Nery F, Reese H, Pollack MH. Levetiracetam as adjunctive therapy for refractory anxiety disorders. J Clin Psychiatry. 2007 Jul; 68(7):1010-3. PMID: 17685735.

Citations:
Pollack M, Mangano R, Entsuah R, Tzanis E, Simon NM, Zhang Y. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Psychopharmacology (Berl). 2007 Oct; 194(2):233-42. PMID: 17589833.

Citations:
Jhaveri M, Seal B, Pollack M, Wertz D. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States. Curr Med Res Opin. 2007 Jun; 23(6):1431-43. PMID: 17559740.

Citations:
Otto MW, O' Cleirigh CM, Pollack MH. Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors. Sci Pract Perspect. 2007 Apr; 3(2):48-56. PMID: 17514074.

Citations:
Hinton DE, Nguyen L, Pollack MH. Orthostatic panic as a key Vietnamese reaction to traumatic events: the case of September 11, 2001. Med Anthropol Q. 2007 Mar; 21(1):81-107. PMID: 17405699.

Citations:
Blier P, Keller MB, Pollack MH, Thase ME, Zajecka JM, Dunner DL. Preventing recurrent depression: long-term treatment for major depressive disorder. J Clin Psychiatry. 2007 Mar; 68(3):e06. PMID: 17388700.

Citations:
Davidson JR, Brady K, Mellman TA, Stein MB, Pollack MH. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder. J Clin Psychopharmacol. 2007 Feb; 27(1):85-8. PMID: 17224720.

Citations:
Otto MW, Henin A, Hirshfeld-Becker DR, Pollack MH, Biederman J, Rosenbaum JF. Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. J Anxiety Disord. 2007; 21(7):888-902. PMID: 17276653.

Citations:
Otto MW, Leyro TM, Christian K, Deveney CM, Reese H, Pollack MH, Orr SP. Prediction of "fear" acquisition in healthy control participants in a de novo fear-conditioning paradigm. Behav Modif. 2007 Jan; 31(1):32-51. PMID: 17179530.

Citations:
Pollack MH, Lepola U, Koponen H, Simon NM, Worthington JJ, Emilien G, Tzanis E, Salinas E, Whitaker T, Gao B. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depress Anxiety. 2007; 24(1):1-14. PMID: 16894619.

Citations:
Hoge EA, Austin ED, Pollack MH. Resilience: research evidence and conceptual considerations for posttraumatic stress disorder. Depress Anxiety. 2007; 24(2):139-52. PMID: 16892420.

Citations:
Hoge EA, Tamrakar SM, Christian KM, Mahara N, Nepal MK, Pollack MH, Simon NM. Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. J Nerv Ment Dis. 2006 Dec; 194(12):962-6. PMID: 17164637.

Citations:
Simon NM, Weiss AM, Kradin R, Evans KC, Reese HE, Otto MW, Oppenheimer JE, Smoller JW, Zalta A, Worthington JJ, Pollack MH. The relationship of anxiety disorders, anxiety sensitivity and pulmonary dysfunction with dyspnea-related distress and avoidance. J Nerv Ment Dis. 2006 Dec; 194(12):951-7. PMID: 17164635.

Citations:
Smoller JW, Pollack MH, Wassertheil-Smoller S, Brunner R, Curb D, Torner J, Oberman A, Hendrix SL, Hsia J, Sheps DS. Panic attacks, daily life ischemia, and chest pain in postmenopausal women. Psychosom Med. 2006 Nov-Dec; 68(6):824-32. PMID: 17101813.

Citations:
Simon NM, Zalta AK, Otto MW, Ostacher MJ, Fischmann D, Chow CW, Thompson EH, Stevens JC, Demopulos CM, Nierenberg AA, Pollack MH. The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorder. J Psychiatr Res. 2007 Apr-Jun; 41(3-4):255-64. PMID: 17052730.

Citations:
Hofmann SG, Pollack MH, Otto MW. Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev. 2006 Fall-Winter; 12(3-4):208-17. PMID: 17227287.

Citations:
Simon NM, Pollack MH, Ostacher MJ, Zalta AK, Chow CW, Fischmann D, Demopulos CM, Nierenberg AA, Otto MW. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2007 Jan; 97(1-3):91-9. PMID: 16820212.

Citations:
Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry. 2006 Jul; 189:20-5. PMID: 16816301.

Citations:
Biederman J, Petty C, Faraone SV, Henin A, Hirshfeld-Becker D, Pollack MH, de Figueiredo S, Feeley R, Rosenbaum JF. Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. J Affect Disord. 2006 Aug; 94(1-3):191-7. PMID: 16753222.

Citations:
Hinton DE, Chhean D, Pich V, Pollack MH, Orr SP, Pitman RK. Assessment of posttraumatic stress disorder in Cambodian refugees using the Clinician-Administered PTSD Scale: psychometric properties and symptom severity. J Trauma Stress. 2006 Jun; 19(3):405-9. PMID: 16788999.

Citations:
Hinton DE, Chhean D, Fama JM, Pollack MH, McNally RJ. Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitions. J Anxiety Disord. 2007; 21(1):42-58. PMID: 16650726.

Citations:
Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006 May; 14(2):157-64. PMID: 16756419.

Citations:
Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry. 2006 Sep 01; 60(5):432-5. PMID: 16581033.

Citations:
Pollack MH, Simon NM, Fagiolini A, Pitman R, McNally RJ, Nierenberg AA, Miyahara S, Sachs GS, Perlman C, Ghaemi SN, Thase ME, Otto MW. Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorder. J Clin Psychiatry. 2006 Mar; 67(3):394-9. PMID: 16649825.

Citations:
Simon NM, Hoge EA, Fischmann D, Worthington JJ, Christian KM, Kinrys G, Pollack MH. An open-label trial of risperidone augmentation for refractory anxiety disorders. J Clin Psychiatry. 2006 Mar; 67(3):381-5. PMID: 16649823.

Citations:
Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006 Mar; 63(3):298-304. PMID: 16520435.

Citations:
Evans KC, Dougherty DD, Pollack MH, Rauch SL. Using neuroimaging to predict treatment response in mood and anxiety disorders. Ann Clin Psychiatry. 2006 Jan-Mar; 18(1):33-42. PMID: 16517451.

Citations:
Simon NM, Zalta AK, Worthington JJ, Hoge EA, Christian KM, Stevens JC, Pollack MH. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder. Depress Anxiety. 2006; 23(6):373-6. PMID: 17068858.

Citations:
Hinton DE, Chhean D, Pich V, Um K, Fama JM, Pollack MH. Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysis. J Anxiety Disord. 2006; 20(2):119-38. PMID: 16464700.

Citations:
Hinton DE, Pich V, Safren SA, Pollack MH, McNally RJ. Anxiety sensitivity among Cambodian refugees with panic disorder: A factor analytic investigation. J Anxiety Disord. 2006; 20(3):281-95. PMID: 16564433.

Citations:
Hinton DE, Pich V, Chhean D, Safren SA, Pollack MH. Somatic-focused therapy for traumatized refugees: Treating posttraumatic stress disorder and comorbid neck-focused panic attacks among cambodian refugees. Psychotherapy (Chic). 2006; 43(4):491-505. PMID: 22122139.

Citations:
Hinton DE, Hinton L, Tran M, Nguyen L, Hsia C, Pollack MH. Orthostatically induced panic attacks among Vietnamese refugees: associated psychopathology, flashbacks, and catastrophic cognitions. Depress Anxiety. 2006; 23(2):113-5. PMID: 16402369.

Citations:
Lyoo IK, Pollack MH, Silveri MM, Ahn KH, Diaz CI, Hwang J, Kim SJ, Yurgelun-Todd DA, Kaufman MJ, Renshaw PF. Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl). 2006 Jan; 184(2):139-44. PMID: 16369836.

Citations:
Hinton DE, Pich V, Safren SA, Pollack MH, McNally RJ. Anxiety sensitivity in traumatized Cambodian refugees: a discriminant function and factor analytic investigation. Behav Res Ther. 2005 Dec; 43(12):1631-43. PMID: 16239155.

Citations:
Martinez JM, Marangell LB, Simon NM, Miyahara S, Wisniewski SR, Harrington J, Pollack MH, Sachs GS, Thase ME. Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. Psychiatr Serv. 2005 Dec; 56(12):1541-8. PMID: 16339616.

Citations:
Hinton DE, Chhean D, Pich V, Safren SA, Hofmann SG, Pollack MH. A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design. J Trauma Stress. 2005 Dec; 18(6):617-29. PMID: 16382423.

Citations:
Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K. The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study. J Clin Psychiatry. 2005 Nov; 66(11):1401-8. PMID: 16420077.

Citations:
Simon NM, Pollack MH, Fischmann D, Perlman CA, Muriel AC, Moore CW, Nierenberg AA, Shear MK. Complicated grief and its correlates in patients with bipolar disorder. J Clin Psychiatry. 2005 Sep; 66(9):1105-10. PMID: 16187766.

Citations:
Pollack MH, Simon NM, Zalta AK, Worthington JJ, Hoge EA, Mick E, Kinrys G, Oppenheimer J. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry. 2006 Feb 01; 59(3):211-5. PMID: 16139813.

Citations:
Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry. 2005 Sep; 62(9):1022-30. PMID: 16143734.

Citations:
Otto MW, Simon NM, Powers M, Hinton D, Zalta AK, Pollack MH. Rates of isolated sleep paralysis in outpatients with anxiety disorders. J Anxiety Disord. 2006; 20(5):687-93. PMID: 16099138.

Citations:
Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Rauf A, Scott M, Pollack M, Rosenbaum JF. Childhood antecedents to panic disorder in referred and nonreferred adults. J Child Adolesc Psychopharmacol. 2005 Aug; 15(4):549-61. PMID: 16190787.

Citations:
Simon NM, Parker SW, Wernick-Robinson M, Oppenheimer JE, Hoge EA, Worthington JJ, Korbly NB, Pollack MH. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics. 2005 Jul-Aug; 46(4):334-9. PMID: 16000676.

Citations:
Simon NM, Otto MW, Fischmann D, Racette S, Nierenberg AA, Pollack MH, Smoller JW. Panic disorder and bipolar disorder: anxiety sensitivity as a potential mediator of panic during manic states. J Affect Disord. 2005 Jul; 87(1):101-5. PMID: 15894380.

Citations:
Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, Bowden CL, Nierenberg AA, Pollack MH, Salloum IM, Simon NM, Thase ME, Sachs GS. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005 Jun; 66(6):730-5; quiz 808-9. PMID: 15960566.

Citations:
Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, Pollack MH, Ostacher MJ, Yan L, Siegel R, Sachs GS. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005 Jun 01; 57(11):1467-73. PMID: 15950022.

Citations:
Hinton DE, Pich V, Chhean D, Pollack MH. 'The ghost pushes you down': sleep paralysis-type panic attacks in a Khmer refugee population. Transcult Psychiatry. 2005 Mar; 42(1):46-77. PMID: 15881268.

Citations:
Stevens JC, Pollack MH. Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents. J Clin Psychiatry. 2005; 66 Suppl 2:21-7. PMID: 15762816.

Citations:
Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry. 2005; 66 Suppl 8:22-9. PMID: 16336033.

Citations:
Pollack MH. The pharmacotherapy of panic disorder. J Clin Psychiatry. 2005; 66 Suppl 4:23-7. PMID: 15842184.

Citations:
Stewart SA, Rosenbaum JF, Pollack MH, Roy-Byrne PP, O'Brien CP, Otto MW. Discussion: using benzodiazepines in clinical practice. J Clin Psychiatry. 2005; 66 Suppl 2:39-43; quiz 44-5. PMID: 15762819.

Citations:
Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Pollack MH, Rosenbaum JF. Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample. Depress Anxiety. 2005; 21(2):55-60. PMID: 15816058.

Citations:
Hinton DE, Pich V, Chhean D, Pollack MH, McNally RJ. Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severity. Depress Anxiety. 2005; 22(2):47-51. PMID: 16094659.

Citations:
Worthington JJ, Kinrys G, Wygant LE, Pollack MH. Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients. Int Clin Psychopharmacol. 2005 Jan; 20(1):9-11. PMID: 15602109.

Citations:
Biederman J, Petty C, Faraone SV, Hirshfeld-Becker DR, Henin A, Dougherty M, Lebel TJ, Pollack M, Rosenbaum JF. Parental predictors of pediatric panic disorder/agoraphobia: a controlled study in high-risk offspring. Depress Anxiety. 2005; 22(3):114-20. PMID: 16193490.

Citations:
Simon NM, Otto MW, Wisniewski SR, Fossey M, Sagduyu K, Frank E, Sachs GS, Nierenberg AA, Thase ME, Pollack MH. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004 Dec; 161(12):2222-9. PMID: 15569893.

Citations:
Otto MW, Perlman CA, Wernicke R, Reese HE, Bauer MS, Pollack MH. Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies. Bipolar Disord. 2004 Dec; 6(6):470-9. PMID: 15541062.

Citations:
Simon NM, Otto MW, Weiss RD, Bauer MS, Miyahara S, Wisniewski SR, Thase ME, Kogan J, Frank E, Nierenberg AA, Calabrese JR, Sachs GS, Pollack MH. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol. 2004 Oct; 24(5):512-20. PMID: 15349007.

Citations:
Hinton DE, Pham T, Tran M, Safren SA, Otto MW, Pollack MH. CBT for Vietnamese refugees with treatment-resistant PTSD and panic attacks: a pilot study. J Trauma Stress. 2004 Oct; 17(5):429-33. PMID: 15633922.

Citations:
Silveri MM, Pollack MH, Diaz CI, Nassar LE, Mendelson JH, Yurgelun-Todd DA, Renshaw PF, Kaufman MJ. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment. Psychiatry Res. 2004 Sep 15; 131(3):217-26. PMID: 15465291.

Citations:
Hinton DE, Pich V, Chhean D, Pollack MH, Barlow DH. Olfactory-triggered panic attacks among Cambodian refugees attending a psychiatric clinic. Gen Hosp Psychiatry. 2004 Sep-Oct; 26(5):390-7. PMID: 15474639.

Citations:
Simon NM, Otto MW, Smits JA, Nicolaou DC, Reese HE, Pollack MH. Changes in anxiety sensitivity with pharmacotherapy for panic disorder. J Psychiatr Res. 2004 Sep-Oct; 38(5):491-5. PMID: 15380399.

Citations:
Simon NM, Worthington JJ, Doyle AC, Hoge EA, Kinrys G, Fischmann D, Link N, Pollack MH. An open-label study of levetiracetam for the treatment of social anxiety disorder. J Clin Psychiatry. 2004 Sep; 65(9):1219-22. PMID: 15367048.

Citations:
Lyoo IK, Streeter CC, Ahn KH, Lee HK, Pollack MH, Silveri MM, Nassar L, Levin JM, Sarid-Segal O, Ciraulo DA, Renshaw PF, Kaufman MJ. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004 Jul 30; 131(2):135-45. PMID: 15313520.

Citations:
Stein MB, Pollack MH, Bystritsky A, Kelsey JE, Mangano RM. Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berl). 2005 Jan; 177(3):280-8. PMID: 15258718.

Citations:
Hinton D, Pich V, Chhean D, Pollack M. Olfactory-triggered panic attacks among Khmer refugees: a contextual approach. Transcult Psychiatry. 2004 Jun; 41(2):155-99. PMID: 15446720.

Citations:
Biederman J, Petty C, Faraone SV, Hirshfeld-Becker D, Pollack MH, Henin A, Gilbert J, Rosenbaum JF. Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res. 2004 Apr 30; 126(2):143-9. PMID: 15123393.

Citations:
Pande AC, Feltner DE, Jefferson JW, Davidson JR, Pollack M, Stein MB, Lydiard RB, Futterer R, Robinson P, Slomkowski M, DuBoff E, Phelps M, Janney CA, Werth JL. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study. J Clin Psychopharmacol. 2004 Apr; 24(2):141-9. PMID: 15206660.

Citations:
Pollack MH. Unmet needs in the treatment of anxiety disorders. Psychopharmacol Bull. 2004; 38(1):31-7. PMID: 15278016.

Citations:
Doyle A, Pollack MH. Long-term management of panic disorder. J Clin Psychiatry. 2004; 65 Suppl 5:24-8. PMID: 15078115.

Citations:
Otto MW, Safren SA, Pollack MH. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. J Anxiety Disord. 2004; 18(1):69-87. PMID: 14725869.

Citations:
Blais MA, Holdwick DJ, McLean RY, Otto MW, Pollack MH, Hilsenroth MJ. Exploring the psychometric properties and construct validity of the MCMI-III anxiety and avoidant personality scales. J Pers Assess. 2003 Dec; 81(3):237-41. PMID: 14638448.

Citations:
Otto MW, Hinton D, Korbly NB, Chea A, Ba P, Gershuny BS, Pollack MH. Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther. 2003 Nov; 41(11):1271-6. PMID: 14527527.

Citations:
Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD, Dicken T, Oberman A, Sheps DS. Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative. Arch Intern Med. 2003 Sep 22; 163(17):2041-50. PMID: 14504117.

Citations:
Pollack MH, Simon NM, Worthington JJ, Doyle AL, Peters P, Toshkov F, Otto MW. Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder. J Psychopharmacol. 2003 Sep; 17(3):276-82. PMID: 14513919.

Citations:
Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, Nutt DJ, Okasha A, Swinson RP. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):17-30. PMID: 14767395.

Citations:
Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of social phobia. CNS Spectr. 2003 Aug; 8(8 Suppl 1):40-52. PMID: 14767397.

Citations:
Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):53-61. PMID: 14767398.

Citations:
Stein DJ, Bandelow B, Hollander E, Nutt DJ, Okasha A, Pollack MH, Swinson RP, Zohar J. WCA Recommendations for the long-term treatment of posttraumatic stress disorder. CNS Spectr. 2003 Aug; 8(8 Suppl 1):31-9. PMID: 14767396.

Citations:
Manfro GG, Isolan L, Blaya C, Maltz S, Heldt E, Pollack MH. Relationship between adult social phobia and childhood anxiety. Braz J Psychiatry. 2003 Jun; 25(2):96-9. PMID: 12975706.

Citations:
Pollack MH, Meoni P, Otto MW, Simon N, Hackett D. Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studies. J Clin Psychopharmacol. 2003 Jun; 23(3):250-9. PMID: 12826987.

Citations:
Huffman JC, Pollack MH. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics. 2003 May-Jun; 44(3):222-36. PMID: 12724504.

Citations:
Kinrys G, Pollack MH, Simon NM, Worthington JJ, Nardi AE, Versiani M. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharmacol. 2003 May; 18(3):169-72. PMID: 12702897.

Citations:
Manfro GG, Alexandre Netto C, Pollack M, Mezzomo KM, Preffer F, Kradin R. Stress regulates the lymphocyte homing receptor CD62L (L-selectin). Arq Neuropsiquiatr. 2003 Mar; 61(1):20-4. PMID: 12715014.

Citations:
Roy-Byrne P, Russo J, Pollack M, Stewart R, Bystrisky A, Bell J, Rosenbaum J, Corrigan MH, Stolk J, Rush AJ, Ballenger J. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychol Med. 2003 Apr; 33(3):511-8. PMID: 12701671.

Citations:
Hagengimana A, Hinton D, Bird B, Pollack M, Pitman RK. Somatic panic-attack equivalents in a community sample of Rwandan widows who survived the 1994 genocide. Psychiatry Res. 2003 Jan 25; 117(1):1-9. PMID: 12581815.

Citations:
Doyle AC, Pollack MH. Establishment of remission criteria for anxiety disorders. J Clin Psychiatry. 2003; 64 Suppl 15:40-5. PMID: 14658990.

Citations:
Simon NM, Emmanuel N, Ballenger J, Worthington JJ, Kinrys G, Korbly NB, Farach FJ, Pollack MH. Bupropion sustained release for panic disorder. Psychopharmacol Bull. 2003; 37(4):66-72. PMID: 15131517.

Citations:
Pollack MH, Doyle AC. Treatment of panic disorder: focus on paroxetine. Psychopharmacol Bull. 2003; 37 Suppl 1:53-63. PMID: 14566201.

Citations:
Pollack MH, Penava SA, Bolton E, Worthington JJ, Allen GL, Farach FJ, Otto MW. A novel cognitive-behavioral approach for treatment-resistant drug dependence. J Subst Abuse Treat. 2002 Dec; 23(4):335-42. PMID: 12495795.

Citations:
Simon NM, Korbly NB, Worthington JJ, Kinrys G, Pollack MH. Citalopram for social anxiety disorder: an open-label pilot study in refractory and nonrefractory patients. CNS Spectr. 2002 Sep; 7(9):655-7. PMID: 15097929.

Citations:
Safren SA, Gershuny BS, Marzol P, Otto MW, Pollack MH. History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorder. J Nerv Ment Dis. 2002 Jul; 190(7):453-6. PMID: 12142846.

Citations:
Simon NM, Safren SA, Otto MW, Sharma SG, Lanka GD, Pollack MH. Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder. J Affect Disord. 2002 May; 69(1-3):201-8. PMID: 12103467.

Citations:
Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord. 2002 May; 69(1-3):209-17. PMID: 12103468.

Citations:
Huffman JC, Pollack MH, Stern TA. Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management. Prim Care Companion J Clin Psychiatry. 2002 Apr; 4(2):54-62. PMID: 15014745.

Citations:
Perlis RH, Fava M, Nierenberg AA, Pollack MH, Falk WE, Kienke AS, Rosenbaum JF. Strategies for treatment of SSRI-associated sexual dysfunction: a survey of an academic psychopharmacology practice. Harv Rev Psychiatry. 2002 Mar-Apr; 10(2):109-14. PMID: 11897751.

Citations:
Pollack MH. New advances in the management of anxiety disorders. Psychopharmacol Bull. 2002; 36(4):79-94. PMID: 12858146.

Citations:
Otto MW, Tuby KS, Gould RA, McLean RY, Pollack MH. An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry. 2001 Dec; 158(12):1989-92. PMID: 11729014.

Citations:
Rapaport MH, Wolkow R, Rubin A, Hackett E, Pollack M, Ota KY. Sertraline treatment of panic disorder: results of a long-term study. Acta Psychiatr Scand. 2001 Oct; 104(4):289-98. PMID: 11722304.

Citations:
Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001 May; 62(5):350-7. PMID: 11411817.

Citations:
Smoller JW, Acierno JS, Rosenbaum JF, Biederman J, Pollack MH, Meminger S, Pava JA, Chadwick LH, White C, Bulzacchelli M, Slaugenhaupt SA. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet. 2001 Mar 08; 105(2):195-206. PMID: 11304837.

Citations:
Otto MW, Pollack MH, Maki KM, Gould RA, Worthington JJ, Smoller JW, Rosenbaum JF. Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorder. Depress Anxiety. 2001; 14(4):209-13. PMID: 11754127.

Citations:
Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001; 13(4):166-78. PMID: 11413563.

Citations:
Safren SA, Lanka GD, Otto MW, Pollack MH. Prevalence of childhood ADHD among patients with Generalized Anxiety Disorder and a comparison condition, Social Phobia. Depress Anxiety. 2001; 13(4):190-1. PMID: 11413566.

Citations:
Pollack MH. Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder. J Clin Psychiatry. 2001; 62 Suppl 12:24-9. PMID: 11430615.

Citations:
Uhlenhuth EH, Matuzas W, Warner TD, Paine S, Lydiard RB, Pollack MH. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication. J Clin Psychopharmacol. 2000 Dec; 20(6):622-7. PMID: 11106133.

Citations:
Pollack MH, Marzol PC. Pharmacotherapeutic options in the treatment of comorbid depression and anxiety. CNS Spectr. 2000 Dec; 5(12):23-30. PMID: 17545962.

Citations:
Marzol PC, Pollack MH. New developments in panic disorder. Curr Psychiatry Rep. 2000 Aug; 2(4):353-7. PMID: 11122981.

Citations:
Otto MW, Pollack MH, Maki KM. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol. 2000 Aug; 68(4):556-63. PMID: 10965630.

Citations:
Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, Lydiard RB, Taylor CB, Dager SR, Shiovitz T. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol. 2000 Aug; 20(4):467-71. PMID: 10917408.

Citations:
Otto MW, Pollack MH, Gould RA, Worthington JJ, McArdle ET, Rosenbaum JF. A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia. J Anxiety Disord. 2000 Jul-Aug; 14(4):345-58. PMID: 11043885.

Citations:
Rapaport MH, Pollack M, Wolkow R, Mardekian J, Clary C. Is placebo response the same as drug response in panic disorder? Am J Psychiatry. 2000 Jun; 157(6):1014-6. PMID: 10831487.

Citations:
Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry. 2000 Jun; 157(6):968-74. PMID: 10831478.

Citations:
Fones CS, Pollack MH, Susswein L, Otto M. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord. 2000 May; 58(2):99-106. PMID: 10781699.

Citations:
Pollack MH. Forum. What are the current treatments for panic disorder? Harv Ment Health Lett. 2000 May; 16(11):8. PMID: 10760973.

Citations:
Iwagaki A, Porro M, Pollack M. Influence of synthetic antiendotoxin peptides on lipopolysaccharide (LPS) recognition and LPS-induced proinflammatory cytokine responses by cells expressing membrane-bound CD14. Infect Immun. 2000 Mar; 68(3):1655-63. PMID: 10678985.

Citations:
Manfro GG, Pollack MH, Otto MW, Worthington JJ, Rosenbaum JF, Scott EL, Kradin RL. Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: correlates with affective parameters and severity of panic disorder. Depress Anxiety. 2000; 11(1):31-7. PMID: 10723633.

Citations:
Akiyama M, Oishi K, Tao M, Matsumoto K, Pollack M. Antibacterial properties of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide-specific monoclonal antibody (MAb) in a murine thigh infection model: combined effects of MAb and ceftazidime. Microbiol Immunol. 2000; 44(8):629-35. PMID: 11021392.

Citations:
Pollack MH, Marzol PC. Panic: course, complications and treatment of panic disorder. J Psychopharmacol. 2000; 14(2 Suppl 1):S25-30. PMID: 10888028.

Citations:
Scott EL, Pollack MH, Otto MW, Simon NM, Worthington JJ. Clinician response to treatment refractory panic disorder: a survey of psychiatrists. J Nerv Ment Dis. 1999 Dec; 187(12):755-7. PMID: 10665472.

Citations:
Otto MW, Pollack MH, Penava SJ, Zucker BG. Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70. PMID: 10452176.

Citations:
McNally RJ, Otto MW, Yap L, Pollack MH, Hornig CD. Is panic disorder linked to cognitive avoidance of threatening information? J Anxiety Disord. 1999 Jul-Aug; 13(4):335-48. PMID: 10504105.

Citations:
Candilis PJ, McLean RY, Otto MW, Manfro GG, Worthington JJ, Penava SJ, Marzol PC, Pollack MH. Quality of life in patients with panic disorder. J Nerv Ment Dis. 1999 Jul; 187(7):429-34. PMID: 10426463.

Citations:
Kaufman MJ, Pollack MH, Villafuerte RA, Kukes TJ, Rose SL, Mendelson JH, Cohen BM, Renshaw PF. Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance. Psychiatry Res. 1999 Jun 30; 90(3):143-52. PMID: 10466733.

Citations:
Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999 May; 156(5):756-60. PMID: 10327910.

Citations:
Smoller JW, Simon NM, Pollack MH, Kradin R, Stern T. Anxiety in patients with pulmonary disease: comorbidity and treatment. Semin Clin Neuropsychiatry. 1999 Apr; 4(2):84-97. PMID: 10378952.

Citations:
Michelson D, Pollack M, Lydiard RB, Tamura R, Tepner R, Tollefson G. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group. Br J Psychiatry. 1999 Mar; 174:213-8. PMID: 10448445.

Citations:
Pollack MH. Social anxiety disorder: designing a pharmacologic treatment strategy. J Clin Psychiatry. 1999; 60 Suppl 9:20-6. PMID: 10335676.

Citations:
Michelson D, Lydiard RB, Pollack MH, Tamura RN, Hoog SL, Tepner R, Demitrack MA, Tollefson GD. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Am J Psychiatry. 1998 Nov; 155(11):1570-7. PMID: 9812120.

Citations:
Pollack MH, Otto MW, Worthington JJ, Manfro GG, Wolkow R. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry. 1998 Nov; 55(11):1010-6. PMID: 9819070.

Citations:
Penava SJ, Otto MW, Maki KM, Pollack MH. Rate of improvement during cognitive-behavioral group treatment for panic disorder. Behav Res Ther. 1998 Jul-Aug; 36(7-8):665-73. PMID: 9682523.

Citations:
Pollack MH, Matthews J, Scott EL. Gabapentin as a potential treatment for anxiety disorders. Am J Psychiatry. 1998 Jul; 155(7):992-3. PMID: 9659873.

Citations:
Simon NM, Pollack MH, Tuby KS, Stern TA. Dizziness and panic disorder: a review of the association between vestibular dysfunction and anxiety. Ann Clin Psychiatry. 1998 Jun; 10(2):75-80. PMID: 9669539.

Citations:
Smoller JW, McLean RY, Otto MW, Pollack MH. How do clinicians respond to patients who miss appointments? J Clin Psychiatry. 1998 Jun; 59(6):330-8; quiz 339-40. PMID: 9671351.

Citations:
Otto MW, Demopulos CM, McLean NE, Pollack MH, Fava M. Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depression. J Anxiety Disord. 1998 May-Jun; 12(3):225-32. PMID: 9653681.

Citations:
Worthington JJ, Pollack MH, Otto MW, McLean RY, Moroz G, Rosenbaum JF. Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder. Psychopharmacol Bull. 1998; 34(2):199-205. PMID: 9641001.

Citations:
Fones CS, Manfro GG, Pollack MH. Social phobia: an update. Harv Rev Psychiatry. 1998 Jan-Feb; 5(5):247-59. PMID: 9493947.

Citations:
Worthington JJ, Zucker BG, Fones CS, Otto MW, Pollack MH. Nefazodone for social phobia: a clinical case series. Depress Anxiety. 1998; 8(3):131-3. PMID: 9836065.

Citations:
Smoller JW, Pollack MH, Systrom D, Kradin RL. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics. 1998 Jan-Feb; 39(1):24-9. PMID: 9538672.

Citations:
Labbate LA, Grimes JB, Hines A, Pollack MH. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997 Dec; 9(4):241-5. PMID: 9511948.

Citations:
Pollack M, Ohl CA, Golenbock DT, Di Padova F, Wahl LM, Koles NL, Guelde G, Monks BG. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions. J Immunol. 1997 Oct 01; 159(7):3519-30. PMID: 9317151.

Citations:
Wilhelm S, Otto MW, Zucker BG, Pollack MH. Prevalence of body dysmorphic disorder in patients with anxiety disorders. J Anxiety Disord. 1997 Sep-Oct; 11(5):499-502. PMID: 9407269.

Citations:
Noyes R, Moroz G, Davidson JR, Liebowitz MR, Davidson A, Siegel J, Bell J, Cain JW, Curlik SM, Kent TA, Lydiard RB, Mallinger AG, Pollack MH, Rapaport M, Rasmussen SA, Hedges D, Schweizer E, Uhlenhuth EH. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol. 1997 Aug; 17(4):247-54. PMID: 9241002.

Citations:
McNally RJ, Hornig CD, Otto MW, Pollack MH. Selective encoding of threat in panic disorder: application of a dual priming paradigm. Behav Res Ther. 1997 Jun; 35(6):543-9. PMID: 9159978.

Citations:
Preston MJ, Ger?eker AA, Koles NL, Pollack M, Pier GB. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Invest Ophthalmol Vis Sci. 1997 Jun; 38(7):1418-25. PMID: 9191605.

Citations:
Candilis PJ, Pollack MH. The hidden costs of untreated anxiety disorders. Harv Rev Psychiatry. 1997 May-Jun; 5(1):40-2. PMID: 9385019.

Citations:
Worthington JJ, Pollack MH, Otto MW, Gould RA, Sabatino SA, Goldman L, Rosenbaum JF, Lee TH. Panic disorder in emergency ward patients with chest pain. J Nerv Ment Dis. 1997 Apr; 185(4):274-6. PMID: 9114814.

Citations:
Pollack MH, Otto MW. Long-term course and outcome of panic disorder. J Clin Psychiatry. 1997; 58 Suppl 2:57-60. PMID: 9078996.

Citations:
Pollack MH, Worthington JJ, Manfro GG, Otto MW, Zucker BG. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. J Clin Psychiatry. 1997; 58 Suppl 11:19-23. PMID: 9363044.

Citations:
Manfro GG, Otto MW, McArdle ET, Worthington JJ, Rosenbaum JF, Pollack MH. Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. J Affect Disord. 1996 Nov 25; 41(2):135-9. PMID: 8961041.

Citations:
Bloch Y, Pollack M, Mor I. Should the administration of ECT during clozapine therapy be contraindicated? Br J Psychiatry. 1996 Aug; 169(2):253-4. PMID: 8871811.

Citations:
Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL. Panic anxiety, dyspnea, and respiratory disease. Theoretical and clinical considerations. Am J Respir Crit Care Med. 1996 Jul; 154(1):6-17. PMID: 8680700.

Citations:
Gould RA, Ball S, Kaspi SP, Otto MW, Pollack MH, Shekhar A, Fava M. Prevalence and correlates of anger attacks: a two site study. J Affect Disord. 1996 Jun 20; 39(1):31-8. PMID: 8835651.

Citations:
Pollack MH, Gould RA. The pharmacotherapy of social phobia. Int Clin Psychopharmacol. 1996 Jun; 11 Suppl 3:71-5. PMID: 8923113.

Citations:
Worthington JJ, Pollack MH. Treatment of dysphoric mania with nefazodone. Am J Psychiatry. 1996 May; 153(5):732-3. PMID: 8615426.

Citations:
Pollack MH, Otto MW, Sabatino S, Majcher D, Worthington JJ, McArdle ET, Rosenbaum JF. Relationship of childhood anxiety to adult panic disorder: correlates and influence on course. Am J Psychiatry. 1996 Mar; 153(3):376-81. PMID: 8610825.

Citations:
Pollack MH, Worthington JJ, Otto MW, Maki KM, Smoller JW, Manfro GG, Rudolph R, Rosenbaum JF. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study. Psychopharmacol Bull. 1996; 32(4):667-70. PMID: 8993089.

Citations:
Pollack MH, Kradin R, Otto MW, Worthington J, Gould R, Sabatino SA, Rosenbaum JF. Prevalence of panic in patients referred for pulmonary function testing at a major medical center. Am J Psychiatry. 1996 Jan; 153(1):110-3. PMID: 8540567.

Citations:
Penava SJ, Otto MW, Pollack MH, Rosenbaum JF. Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies. Depress Anxiety. 1996-1997; 4(5):240-2. PMID: 9167791.

Citations:
Rosenbaum JF, Pollack MH, Pollock RA. Clinical issues in the long-term treatment of panic disorder. J Clin Psychiatry. 1996; 57 Suppl 10:44-8; discussion 49-50. PMID: 8917131.

Citations:
Rosenbaum JF, Pollock RA, Jordan SK, Pollack MH. The pharmacotherapy of panic disorder. Bull Menninger Clin. 1996; 60(2 Suppl A):A54-75. PMID: 8857427.

Citations:
Pollack MH, Smoller JW. The longitudinal course and outcome of panic disorder. Psychiatr Clin North Am. 1995 Dec; 18(4):785-801. PMID: 8748381.

Citations:
Pollack M, Koles NL, Preston MJ, Brown BJ, Pier GB. Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide. Infect Immun. 1995 Nov; 63(11):4481-8. PMID: 7591089.

Citations:
Pollack M, Espinoza AM, Guelde G, Koles NL, Wahl LM, Ohl CA. Lipopolysaccharide (LPS)-specific monoclonal antibodies regulate LPS uptake and LPS-induced tumor necrosis factor-alpha responses by human monocytes. J Infect Dis. 1995 Sep; 172(3):794-804. PMID: 7658073.

Citations:
Weilburg JB, Schachter S, Worth J, Pollack MH, Sachs GS, Ives JR, Schomer DL. EEG abnormalities in patients with atypical panic attacks. J Clin Psychiatry. 1995 Aug; 56(8):358-62. PMID: 7635852.

Citations:
Otto MW, Pollack MH, Ball SG, Rosenbaum JF. Integration of behavioral and pharmacological treatments for panic disorder: implications for the treatment of substance dependence. NIDA Res Monogr. 1995; 150:143-66. PMID: 8742777.

Citations:
Rosenbaum JF, Pollock RA, Otto MW, Pollack MH. Integrated treatment of panic disorder. Bull Menninger Clin. 1995; 59(2 Suppl A):A4-26. PMID: 7795571.

Citations:
Jobson KO, Davidson JR, Lydiard RB, McCann UD, Pollack MH, Rosenbaum JF. Algorithm for the treatment of panic disorder with agoraphobia. Psychopharmacol Bull. 1995; 31(3):483-5. PMID: 8668753.

Citations:
Shear MK, Leon AC, Pollack MH, Rosenbaum JF, Keller MB. Pattern of placebo response in panic disorder. Psychopharmacol Bull. 1995; 31(2):273-8. PMID: 7491379.

Citations:
Otto MW, McNally RJ, Pollack MH, Chen E, Rosenbaum JF. Hemispheric laterality and memory bias for threat in anxiety disorders. J Abnorm Psychol. 1994 Nov; 103(4):828-831. PMID: 7822587.

Citations:
Otto MW, Pollack MH. Treatment strategies for panic disorder: a debate. Harv Rev Psychiatry. 1994 Sep-Oct; 2(3):166-70. PMID: 9384898.

Citations:
Labbate LA, Pollack MH, Otto MW, Tesar GM, Rosenbaum JF. The relationship of alprazolam and clonazepam dose to steady-state concentration in plasma. J Clin Psychopharmacol. 1994 Aug; 14(4):274-6. PMID: 7962684.

Citations:
Labbate LA, Pollack MH, Otto MW, Langenauer S, Rosenbaum JF. Sleep panic attacks: an association with childhood anxiety and adult psychopathology. Biol Psychiatry. 1994 Jul 01; 36(1):57-60. PMID: 8080905.

Citations:
Pollack MH, Otto MW, Kaspi SP, Hammerness PG, Rosenbaum JF. Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994 May; 55(5):200-5. PMID: 8071270.

Citations:
Ball SG, Otto MW, Pollack MH, Rosenbaum JF. Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. J Consult Clin Psychol. 1994 Apr; 62(2):359-65. PMID: 8201074.

Citations:
Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81. PMID: 8014326.

Citations:
Pier GB, Koles NL, Meluleni G, Hatano K, Pollack M. Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infect Immun. 1994 Apr; 62(4):1137-43. PMID: 8132318.

Citations:
Hoffman WD, Pollack M, Banks SM, Koev LA, Solomon MA, Danner RL, Koles N, Guelde G, Yatsiv I, Mouginis T, et al. Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharide. J Infect Dis. 1994 Mar; 169(3):553-61. PMID: 7512609.

Citations:
Labbate LA, Pollack MH. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry. 1994 Mar; 6(1):13-5. PMID: 7951639.

Citations:
Otto MW, Pollack MH, Rosenbaum JF, Sachs GS, Asher RH. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harv Rev Psychiatry. 1994 Jan-Feb; 1(5):288-93. PMID: 9384860.

Citations:
Pollack MH. Innovative uses of benzodiazepines in psychiatry. Can J Psychiatry. 1993 Nov; 38 Suppl 4:S122-6. PMID: 7905781.

Citations:
Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90. PMID: 8379551.

Citations:
Pollack MH, Otto MW, Tesar GE, Cohen LS, Meltzer-Brody S, Rosenbaum JF. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol. 1993 Aug; 13(4):257-63. PMID: 8376613.

Citations:
Field S, Pollack M, Morrison DC. Development of an anti-idiotype monoclonal antibody mimicking the structure of lipopolysaccharide (LPS) inner-core determinants. Microb Pathog. 1993 Aug; 15(2):103-20. PMID: 8255205.

Citations:
Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K, et al. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38. PMID: 8326078.

Citations:
Pollack MH, Hammerness P. Adjunctive yohimbine for treatment in refractory depression. Biol Psychiatry. 1993 Feb 01; 33(3):220-1. PMID: 8448273.

Citations:
Oishi K, Sonoda F, Iwagaki A, Ponglertnapagorn P, Watanabe K, Nagatake T, Siadak A, Pollack M, Matsumoto K. Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia. Antimicrob Agents Chemother. 1993 Feb; 37(2):164-70. PMID: 8383936.

Citations:
Siegel SA, Evans ME, Pollack M, Leone AO, Kinney CS, Tam SH, Daddona PE. Antibiotics enhance binding by human lipid A-reactive monoclonal antibody HA-1A to smooth gram-negative bacteria. Infect Immun. 1993 Feb; 61(2):512-9. PMID: 8423081.

Citations:
Weilburg JB, Schachter S, Sachs GS, Worth J, Pollack MH, Ives JR, Schomer DL. Focal paroxysmal EEG changes during atypical panic attacks. J Neuropsychiatry Clin Neurosci. 1993; 5(1):50-5. PMID: 8428135.

Citations:
Ries AA, Vugia DJ, Beingolea L, Palacios AM, Vasquez E, Wells JG, Garcia Baca N, Swerdlow DL, Pollack M, Bean NH, et al. Cholera in Piura, Peru: a modern urban epidemic. J Infect Dis. 1992 Dec; 166(6):1429-33. PMID: 1431259.

Citations:
Evans ME, Pollack M, Koles NL, Hardegen NJ, Panopoulos D. Lipopolysaccharide heterogeneity in Escherichia coli J5 variants: analysis by flow cytometry. J Infect Dis. 1992 Oct; 166(4):803-11. PMID: 1527415.

Citations:
Pollack MH, Otto MW, Rosenbaum JF, Sachs GS. Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Compr Psychiatry. 1992 Mar-Apr; 33(2):78-83. PMID: 1544300.

Citations:
Pollack MH, Reiter S, Hammerness P. Genitourinary and sexual adverse effects of psychotropic medication. Int J Psychiatry Med. 1992; 22(4):305-27. PMID: 1363418.

Citations:
Otto MW, Pollack MH, Sachs GS, O'Neil CA, Rosenbaum JF. Alcohol dependence in panic disorder patients. J Psychiatr Res. 1992 Jan; 26(1):29-38. PMID: 1560407.

Citations:
Otto MW, Pollack MH, Meltzer-Brody S, Rosenbaum JF. Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients. Psychopharmacol Bull. 1992; 28(2):123-30. PMID: 1355299.

Citations:
Oishi K, Koles NL, Guelde G, Pollack M. Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity. J Infect Dis. 1992 Jan; 165(1):34-45. PMID: 1727896.

Citations:
Reiter SR, Otto MW, Pollack MH, Rosenbaum JF. Major depression in panic disorder patients with comorbid social phobia. J Affect Disord. 1991 Jul; 22(3):171-7. PMID: 1918660.

Citations:
Pollack MH, Sachs GS, Tesar GE, Shushtari J, Herman JB, Otto MW, Rosenbaum JF. Pilot outreach services to homebound agoraphobic patients. Hosp Community Psychiatry. 1991 Mar; 42(3):315-7. PMID: 2030018.

Citations:
Tesar GE, Rosenbaum JF, Pollack MH, Otto MW, Sachs GS, Herman JB, Cohen LS, Spier SA. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991 Feb; 52(2):69-76. PMID: 1993639.

Citations:
Pollack M, Tao M, Akiyama M, Pier GB, Koles NL. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides. Antibiot Chemother (1971). 1991; 44:163-71. PMID: 1801635.

Citations:
Oishi K, Sonoda F, Miwa H, Tanaka H, Watanabe K, Matsumoto K, Pollack M. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice. Microbiol Immunol. 1991; 35(12):1131-41. PMID: 1808464.

Citations:
Pollack MH, Rosenbaum JF. Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry. 1991 Jan; 52(1):31-3. PMID: 1988415.

Citations:
Pollack MH, Otto MW, Rosenbaum JF, Sachs GS, O'Neil C, Asher R, Meltzer-Brody S. Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry. 1990 Dec; 51 Suppl A:12-6. PMID: 2258371.

Citations:
Reiter SR, Pollack MH, Rosenbaum JF, Cohen LS. Clonazepam for the treatment of social phobia. J Clin Psychiatry. 1990 Nov; 51(11):470-2. PMID: 2228982.

Citations:
Evans ME, Pollack M, Hardegen NJ, Koles NL, Guelde G, Chia JK. Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria. J Infect Dis. 1990 Jul; 162(1):148-55. PMID: 2355191.

Citations:
Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS. The antidepressant potential of oral S-adenosyl-l-methionine. Acta Psychiatr Scand. 1990 May; 81(5):432-6. PMID: 2113347.

Citations:
Pollack MH. Long-term management of panic disorder. J Clin Psychiatry. 1990 May; 51 Suppl:11-3; discussion 50-3. PMID: 1970813.

Citations:
Herman JB, Brotman AW, Pollack MH, Falk WE, Biederman J, Rosenbaum JF. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry. 1990 Jan; 51(1):25-7. PMID: 2295587.

Citations:
Pollack M, Oishi K, Chia J, Evans M, Guelde G, Koles N. Specificity and function of monoclonal antibodies reactive with discrete structural elements of bacterial lipopolysaccharide. Adv Exp Med Biol. 1990; 256:331-40. PMID: 1691578.

Citations:
Fava M, Rosenbaum JF, MacLaughlin R, Falk WE, Pollack MH, Cohen LS, Jones L, Pill L. Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressant. J Psychiatr Res. 1990; 24(2):177-84. PMID: 2120432.

Citations:
Mahoney JD, Gross PL, Stern TA, Browne BJ, Pollack MH, Reder V, Mulley AG. Quantitative serum toxic screening in the management of suspected drug overdose. Am J Emerg Med. 1990 Jan; 8(1):16-22. PMID: 2293827.

Citations:
Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelly K. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9. PMID: 2600061.

Citations:
Fava M, Rosenbaum JF, MacLaughlin RA, Tesar GE, Pollack MH, Cohen LS, Hirsch M. Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder. Psychiatry Res. 1989 Jun; 28(3):345-50. PMID: 2527376.

Citations:
Chia JK, Pollack M, Guelde G, Koles NL, Miller M, Evans ME. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J Infect Dis. 1989 May; 159(5):872-80. PMID: 2651532.

Citations:
Pollack M, Chia JK, Koles NL, Miller M, Guelde G. Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J Infect Dis. 1989 Feb; 159(2):168-88. PMID: 2915151.

Citations:
Pier GB, Pollack M. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide. Infect Immun. 1989 Feb; 57(2):426-31. PMID: 2492260.

Citations:
Rosenbaum JF, Falk WE, Gastfriend DR, Gross CC, Pollack MH, Tesar GE, Weilburg JB. Acute distress after switch from Norpramin to generic desipramine. Am J Psychiatry. 1989 Jan; 146(1):122. PMID: 2912233.

Citations:
Pollack MH, Brotman AW, Rosenbaum JF. Cocaine abuse and treatment. Compr Psychiatry. 1989 Jan-Feb; 30(1):31-44. PMID: 2647400.

Citations:
Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report. Ala J Med Sci. 1988 Jul; 25(3):301-6. PMID: 3052138.

Citations:
Rosenbaum JF, Pollack MH. Anhedonic ejaculation with desipramine. Int J Psychiatry Med. 1988; 18(1):85-8. PMID: 3397227.

Citations:
Pollack M, Chia JK, Koles NL, Miller M, Guelde G. Monoclonal antibodies that recognize epitopes in the core and lipid A region of lipopolysaccharides. Prog Clin Biol Res. 1988; 272:327-38. PMID: 2455917.

Citations:
Rosenbaum JF, Fava M, Falk WE, Pollack MH, Cohen LS, Cohen BM, Zubenko GS. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results. Psychopharmacol Bull. 1988; 24(1):189-94. PMID: 3387521.

Citations:
Pollack MH. Clonazepam: a review of open clinical trials. J Clin Psychiatry. 1987 Oct; 48 Suppl:12-5. PMID: 3312178.

Citations:
Tesar GE, Rosenbaum JF, Pollack MH, Herman JB, Sachs GS, Mahoney EM, Cohen LS, McNamara M, Goldstein S. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21. PMID: 3312179.

Citations:
Pollack MH, Rosenbaum JF, Hyman SE. Calcium channel blockers in psychiatry. Psychosomatics. 1987 Jul; 28(7):356-60, 369. PMID: 3326023.

Citations:
Pollack MH, Rosenbaum JF. Verapamil in the treatment of recurrent unipolar depression. Biol Psychiatry. 1987 Jun; 22(6):779-82. PMID: 3593817.

Citations:
Pollack M, Raubitschek AA, Larrick JW. Human monoclonal antibodies that recognize conserved epitopes in the core-lipid A region of lipopolysaccharides. J Clin Invest. 1987 May; 79(5):1421-30. PMID: 2437155.

Citations:
Pollack MH, Rosenbaum JF. Management of antidepressant-induced side effects: a practical guide for the clinician. J Clin Psychiatry. 1987 Jan; 48(1):3-8. PMID: 3804983.

Citations:
Pollack MH, Rosenbaum JF, Tesar GE, Herman JB, Sachs GS. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4. PMID: 3110854.

Citations:
Tesar GE, Rosenbaum JF, Biederman J, Weilburg JB, Pollack MH, Gross CC, Falk WE, Gastfriend DR, Zusky PM, Bouckoms A. Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull. 1987; 23(1):182-6. PMID: 3602317.

Citations:
Weilburg JB, Pollack M, Murray GB, Garber HJ. On panic attacks and neurologic problems. Am J Psychiatry. 1986 Dec; 143(12):1626-7. PMID: 3789218.

Citations:
Kim EE, Pjura G, Lowry P, Nguyen M, Pollack M. Morphine-augmented cholescintigraphy in the diagnosis of acute cholecystitis. AJR Am J Roentgenol. 1986 Dec; 147(6):1177-9. PMID: 3535452.

Citations:
Pollack MH, Tesar GE, Rosenbaum JF, Spier SA. Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4. PMID: 3771814.

Citations:
Sachs GS, Pollack MH, Brotman AW, Farhadi AM, Gelenberg AJ. Enhancement of ECT benefit by yohimbine. J Clin Psychiatry. 1986 Oct; 47(10):508-10. PMID: 3020009.

Citations:
Stoll BJ, Pollack M, Young LS, Koles N, Gascon R, Pier GB. Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide. Infect Immun. 1986 Sep; 53(3):656-62. PMID: 2427453.

Citations:
Pollack MH, Manschreck TC. Oculocutaneous albinism and schizophrenia. Biol Psychiatry. 1986 Jul; 21(8-9):830-3. PMID: 3730462.

Citations:
Chia JK, Pollack M, Avigan D, Steinbach S. Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A. Infect Immun. 1986 Jun; 52(3):756-62. PMID: 2423458.

Citations:
Rosenbaum JF, Pollack MH. Treatment-emergent incontinence with lithium. J Clin Psychiatry. 1985 Oct; 46(10):444-5. PMID: 3930473.

Citations:
Pollack MH, Rosenbaum JF, Cassem NH. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis. 1985 Feb; 173(2):118-9. PMID: 3968546.

Citations:
Zucker A, Pollack M, Katz R. Blind use of the double-lumen plugged catheter for diagnosis of respiratory tract infections in critically ill children. Crit Care Med. 1984 Oct; 12(10):867-70. PMID: 6488826.

Citations:
Young LS, Wenzel RP, Sabath LD, Pollack M, Pennington JE, Platt R. The outlook for prevention and treatment of infections due to Pseudomonas aeruginosa. Rev Infect Dis. 1984 Sep-Oct; 6 Suppl 3:S769-74. PMID: 6443776.

Citations:
Pollack M. The virulence of Pseudomonas aeruginosa. Rev Infect Dis. 1984 Sep-Oct; 6 Suppl 3:S617-26. PMID: 6443764.

Citations:
Pier GB, Pollack M, Cohen M. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa. Infect Immun. 1984 Aug; 45(2):309-13. PMID: 6430805.

Citations:
Pollack M, Pier GB, Prescott RK. Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice. Infect Immun. 1984 Feb; 43(2):759-60. PMID: 6420347.

Citations:
Pollack M, Huang AI, Prescott RK, Young LS, Hunter KW, Cruess DF, Tsai CM. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. J Clin Invest. 1983 Dec; 72(6):1874-81. PMID: 6358257.

Citations:
Pollack M, Longfield RN, Karney WW. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7. PMID: 6407308.

Citations:
Pollack M. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans. J Infect Dis. 1983 Jun; 147(6):1090-8. PMID: 6406615.

Citations:
Stuart RK, Pollack M. Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro. Infect Immun. 1982 Oct; 38(1):206-11. PMID: 6815089.

Citations:
Pollack M, Prescott RK. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. J Infect Dis. 1982 May; 145(5):688-98. PMID: 6804576.

Citations:
Glassman JM, Soyka JP, Pollack M. Treatment of muscle contraction headache: Micrainin vs. aspirin. Headache. 1982 May; 22(3):101-9. PMID: 7047460.

Citations:
Telles JL, Pollack MH. Feeling sick: the experience and legitimation of illness. Soc Sci Med A. 1981 May; 15(3 Pt 1):243-51. PMID: 6973205.

Citations:
Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield S, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI. Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1980 Dec; 51(6):1316-24. PMID: 6449518.

Citations:
Pollack M. Pseudomonas aeruginosa exotoxin A. N Engl J Med. 1980 Jun 12; 302(24):1360-2. PMID: 6769039.

Citations:
Berdischewsky M, Pollack M, Young LS, Chia D, Osher AB, Barnett EV. Circulating immune complexes in cystic fibrosis. Pediatr Res. 1980 Jun; 14(6):830-3. PMID: 6773019.

Citations:
Bryson YJ, Monahan C, Pollack M, Shields WD. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis. 1980 May; 141(5):543-7. PMID: 7373087.

Citations:
Pollack M, Young LS. Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man. J Clin Invest. 1979 Feb; 63(2):276-86. PMID: 429553.

Citations:
Pollack M, Anderson SE. Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. Infect Immun. 1978 Mar; 19(3):1092-6. PMID: 417028.

Citations:
Taylor NS, Pollack M. Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography. Infect Immun. 1978 Jan; 19(1):66-70. PMID: 415008.

Citations:
Pavlovskis OR, Iglewski BH, Pollack M. Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2. Infect Immun. 1978 Jan; 19(1):29-33. PMID: 415004.

Citations:
Pavlovskis OR, Pollack M, Callahan LT, Iglewski BH. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections. Infect Immun. 1977 Dec; 18(3):596-602. PMID: 412786.

Citations:
Pollack M, Taylor NS. Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay. J Clin Microbiol. 1977 Jul; 6(1):58-61. PMID: 407250.

Citations:
Pollack M, Taylor NS, Callahan LT. Exotoxin production by clinical isolates of pseudomonas aeruginosa. Infect Immun. 1977 Mar; 15(3):776-80. PMID: 404244.

Citations:
Pollack M, Callahan LT, Taylor NS. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Infect Immun. 1976 Oct; 14(4):942-7. PMID: 825470.

Citations:
Pollack M. Significance of circulating capsular antigen in Klebsiella infections. Infect Immun. 1976 Jun; 13(6):1543-8. PMID: 16558119.

Citations:
Woerner MG, Pollack M, Klein DF. Birth weight and length in schizophrenics personality disorders and their siblings. Br J Psychiatry. 1971 Apr; 118(545):461-4. PMID: 5576647.

Citations:
Pollack M, Woerner MG, Goldberg P, Klein DF. Siblings of schizophrenic and nonschizophrenic psychiatric patients. Psychopathology and gender concordance. Arch Gen Psychiatry. 1969 Jun; 20(6):652-8. PMID: 5772542.

Citations:
Levenstein S, Klein DF, Pollack M. Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. Am J Psychiatry. 1966 Apr; 122(10):1102-9. PMID: 5909001.

Citations:
BELMONT I, BIRCH HG, KLEIN DF, POLLACK M, OAKS G. PERCEPTUAL EVIDENCE OF CNS DYSFUNCTION IN SCHIZOPHRENIA. Arch Gen Psychiatry. 1964 Apr; 10:395-408. PMID: 14106964.

Citations:
BLUMBERG AG, KLEIN DF, POLLACK M. EFFECTS OF CHLORPROMAZINE AND IMIPRAMINE ON SYSTOLIC BLOOD PRESSURE IN PSYCHIATRIC PATIENTS: RELATIONSHIPS TO AGE, DIAGNOSIS AND INITIAL BLOOD PRESSURE. J Psychiatr Res. 1964 Jan; 2:51-60. PMID: 14113975.

Citations:
POLLACK M, KAHN RL, KARP E, FINK M. Tachistoscopic perception after induced altered brain function: influence of mental set. J Nerv Ment Dis. 1962 May; 134:422-30. PMID: 14487615.

Citations:
FINK M, KAHN RL, KARP E, POLLACK M, GREEN MA, ALAN B, EFKOWITS HJ. Inhalant-induced convulsions. Significance for the theory of the convulsive therapy process. Arch Gen Psychiatry. 1961 Mar; 4:259-66. PMID: 13699611.

Citations:
POLLACK M, FINK M. Sociopsychological characteristics of patients who refuse convulsive therapy. J Nerv Ment Dis. 1961 Feb; 132:153-7. PMID: 13736830.

Citations:
KAHN RL, POLLACK M, FINK M. Social attitude (California F Scale) and convulsive therapy. J Nerv Ment Dis. 1960 Mar; 130:187-92. PMID: 14404002.

Citations:
FINK M, KAHN RL, POLLACK M. Psychological factors affecting individual differences in behavioral response to convulsive therapy. J Nerv Ment Dis. 1959 Mar; 128(3):243-8. PMID: 13642058.

Citations:

Year	Publications
1994	11
1995	8
1996	12
1997	10
1998	11
1999	9
2000	14
2001	8
2002	8
2003	18
2004	16
2005	23
2006	21
2007	18
2008	19
2009	15
2010	5
2011	7
2012	8
2013	15
2014	6
2015	6
2016	3
2017	9
2018	8
2019	8
2020	8
2021	2
2022	2
2023	2

Pollack's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (856)

Explore

Co-Authors (11)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors